Meaning
Microscopic inflammatory lesions that can form in liver tissue as a response to systemic exposure to absorbed chemical migrants from plastics. The presence of hepatic micro-granulomas indicates a chronic immune response to foreign substances like plasticizers or residual monomers that have migrated into the bloodstream. This toxicity endpoint is monitored during risk assessments for medical-grade polymers.
Toxicity Endpoint
Animal feeding studies measure the dose at which these tissue changes begin to occur. Finding hepatic micro-granulomas at low doses can prevent a new polymer formulation from being approved for medical devices. Evaluators use these studies to establish safe daily intake limits.
Migrant Source
Soft polyvinyl chloride contains high concentrations of plasticizers that can leach into intravenous fluids during medical procedures. When these leached substances are metabolized, they can trigger hepatic micro-granulomas in sensitive tissues. Swapping to non-migrating polymer blends minimizes this biological hazard.
Safety Assessment
Formulators must design medical compounds with low-migration additives to avoid triggering chronic tissue reactions. This risk of hepatic micro-granulomas drives the transition to alternative polymers such as thermoplastic elastomers, which do not require liquid plasticizers that can leach out during clinical use, thereby ensuring that patient tissues remain free of localized inflammatory and immune-mediated lesions over extended courses of treatment.